| CTRI Number |
CTRI/2025/09/095178 [Registered on: 22/09/2025] Trial Registered Prospectively |
| Last Modified On: |
20/09/2025 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Yoga & Naturopathy Behavioral |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Effect OF YOGA INTEGRATED HEALTH EMPOWERMENT PROGRAM ON Health Awareness, Selected physiological Variables and Quality of Life among women with Sickle cell anemia |
|
Scientific Title of Study
|
Impact of yoga integrated health empowerment program on health literacy,
biophysical, biochemical variables and quality of life among women with sickle cell anemia |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
ASHWINI KN |
| Designation |
TUTOR |
| Affiliation |
AIIMS NAGPUR |
| Address |
College of Nursing,4th Floor, Paramedical Academy,
AIIMS CAMPUS,MIHAN
Nagpur MAHARASHTRA 441108 India |
| Phone |
9677139002 |
| Fax |
|
| Email |
ashwinibalaji84@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
ASHWINI KN |
| Designation |
TUTOR |
| Affiliation |
AIIMS NAGPUR |
| Address |
College of Nursing,4th Floor, Paramedical Academy,
AIIMS CAMPUS,MIHAN
Nagpur MAHARASHTRA 441108 India |
| Phone |
9677139002 |
| Fax |
|
| Email |
ashwinibalaji84@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
ASHWINI KN |
| Designation |
TUTOR |
| Affiliation |
AIIMS NAGPUR |
| Address |
College of Nursing,4th Floor, Paramedical Academy,
AIIMS CAMPUS,MIHAN
Nagpur MAHARASHTRA 441108 India |
| Phone |
9677139002 |
| Fax |
|
| Email |
ashwinibalaji84@gmail.com |
|
|
Source of Monetary or Material Support
|
|
|
Primary Sponsor
|
| Name |
ASHWINI KN |
| Address |
TUTOR,COLLEGE OF NURSING,AIIMS NAGPUR |
| Type of Sponsor |
Other [] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr ASHWINI KN |
AIIMS NAGPUR |
Plot No 2 ,Sector 2o, MIHAN CAMPUS, NAGPUR Nagpur MAHARASHTRA |
9677139002
ashwinibalaji84@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| IEC,AIIMS NAGPUR |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: D571||Sickle-cell disease without crisis, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Standard treatment for sickle cell disease including Hydroxyurea |
Standard treatment of Sickle cell anemia includes Hydroxyurea and medical management of symptoms such as analgesics, antibiotics |
| Intervention |
Yoga Integrated Health Empowerment Program |
1. Yoga -pranayama and asanas is conducted as a 40 – 45 minutes session on WEEK 1. Thereafter yoga sessions will be conducted weekly twice by PI and certified yoga instructor at AIIMS Nagpur. Each session consists of
Warm up or relaxation loosening exercises (Sukshama Vyama)- 5 minutes
Pranayama (Kapalabhati and Nadisuddhi)- 20 minutes
Predefined set of asanas (20 minutes)
2. Health empowerment program – one to one health teaching given by PI on SCD using print (pamphlets) and audiovisual media to study group participants during every visit to the hospital. The program will include causes, symptoms, screening, prevention, medical management, diet modification, stress management)
|
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
45.00 Year(s) |
| Gender |
Female |
| Details |
Women who are Clinically proven sickle cell anemic via HPLC,18 - 45 years of age, who are in a steady state (absence of complications and acute VOC atleast for the past one month), have complaints of chronic pain (pain more than 6 months duration with pain score in the range of 4 - 7), Access to smart phone or digital gadgets, willingness for participation followed by clinical consent, Women with noncommunicable diseases in a controlled state and receiving treatment according to standard guidelines will be included in the study. |
|
| ExclusionCriteria |
| Details |
women who are critically ill, known pregnancy and lactation, cognitive or physical impairment, those who are practicing yoga already regularly. |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
Primary -
Mean change in expression of inflammatory biomarker (C reactive protein and TNF alpha), (decreased chronic pain score, stable blood pressure, stable heart rate, stable respiratory rate, stable oxygen saturation, decreased pain during menstruation), health literacy scores , Quality-of-life scores as determined by standardized tool in women with sickle cell anemia from baseline to 3 months in study arm
|
At baseline and end of 12 weeks |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
Secondary-
Mean change in frequency of VOC, prescription need for analgesic use, hospital admissions
|
12 weeks |
|
|
Target Sample Size
|
Total Sample Size="100" Sample Size from India="100"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
01/01/2026 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="3" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Background and Rationale Sickle cell anemia is a prevalent hemolytic disorder in Indian populations, particularly in Central India. Women with sickle cell disease (SCD) suffer both disease-related complications and unique challenges regarding reproductive health, chronic pain, and social functioning. Standard management includes hydroxyurea, pain control, and community interventions, yet frequent vaso-occlusive crises and chronic pain impair life quality. Complementary approaches such as yoga have shown promise for pain reduction, inflammation control, and holistic health support—especially important for women, who may face gaps in conventional care and awareness. This study addresses the need for integrated, evidence-based strategies to enhance self-care, literacy, and psychosocial outcomes among women with SCD. The Objectives of the study are to assess whether a yoga-integrated health empowerment program significantly improves health literacy, biophysical and biochemical markers (including chronic pain scores and inflammation), and quality-of-life indicators, To explore the relationships among health literacy, physical markers, biochemical markers, and quality of life in women with SCD. Methodology: This is a randomized controlled trial (RCT) with two parallel arms: (1) standard medical treatment including hydroxyurea, and (2) standard treatment plus a structured yoga-based health empowerment program. Women aged 18–45 years with clinically proven SCD and stable conditions, who experience chronic pain and possess digital access, will be recruited through the Sickle Cell OPD at AIIMS Nagpur. The yoga module consists of supervised in-person and virtual sessions (pranayama, asana, relaxation) twice weekly, supplemented by ongoing health education (printed and digital materials) on disease management, self-care, and coping strategies. Baseline and post-intervention assessments (at week 13) include validated questionnaires for health literacy, pain score (VAS), quality of life (ASCQ-Me), biophysical measurements, and laboratory testing for inflammatory markers (CRP, TNF-alpha). The total planned sample size is 100 women (50 per group), with tools and procedures detailed for randomization, allocation concealment (SNOSE method), and blinding of assessors where feasible. Careful strategies support intervention adherence, including daily virtual contact, WhatsApp groups, appointment reminders, and family engagement. Adverse events are monitored, with clear criteria for intervention discontinuation and ongoing follow-up for all participants, including post-study care offered to controls. The primary outcomes of the study are mean changes in health literacy, biophysical and biochemical markers, and quality of life over three months. Secondary outcomes include reductions in vaso-occlusive crisis frequency, analgesic requirements, and hospital admissions. Data will be analyzed using intention-to-treat principles, with t-tests, ANCOVA, correlation, and regression analyses applied. All procedures meet ethical standards with informed consent, confidentiality, and IEC oversight. This study innovatively combines yoga therapy with health literacy and empowerment training for women with SCD—a population experiencing high burdens yet low awareness and support. Its rigorous design, validated tools, and strong outcome focus position it to yield actionable insights for integrative, gender-sensitive chronic disease care and policy in India. |